MOLEQLAR

Private

BerlinHealthcare & Life Scienceshttps://moleqlar.com/

Last Round

Seed

Nov 9, 2023

Momentum

Top 5%

of companies Caplight tracks

Company Overview

MOLEQLAR is a biotechnology and food company that develops and distributes science-based longevity products including nutritional supplements and health tests.

Sector

Healthcare & Life Sciences

Verticals

D2C Brands, Biotechnology, E-commerce, Precision Medicine, Subscription Commerce

Business Model

B2C

Customer Profile

Subscription SaaS, Freemium, Services & Consulting

AI Layer

Application

Keywords

longevitylongevity supplementsat-home health testsbiological age testbiohackingNAD testNMN supplementepigeneticspersonalized supplementspreventative healthspermidine supplementDTCsubscription commercecorporate healthchemicals for research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MOLEQLAR Comps

Public and private peers based on sector, stage, and business model.

MOLEQLAR comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

MOLEQLAR Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Nov 9, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Clemens Klingler

Co-Founder And COO

Founding Team

Mario Gietl

Co-Founder & CMO

Founding Team

Max Griessinger

CEO & Founder

Founding Team

MOLEQLAR Investors

Notable investors and investment history

MOLEQLAR investors
Investor	Rounds
Rheingau Founders	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jun 15, 2026
Open roles increased from 0 to 4, representing 25% of headcount.
Jul 23, 2025
Grew 36% QoQ, from 11 to 15 employees.

View all signals

MOLEQLAR Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

MOLEQLAR Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MOLEQLAR's valuation, stock price, and market status.

Firmographic Details

HeadquartersBerlin

Employee Range16

Year Founded2020

Last FundingNov 9, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.